+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genomics Biomarkers Market by Type, by Disease Indication, by Validation, by End- User, and by Region

  • PDF Icon

    Report

  • 200 Pages
  • October 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 6008268
The global genomics biomarkers market accounted for USD 8.94 billion in 2023 and is expected to reach at USD 52.92 billion by 2034 with a CAGR of 17.54% during the forecast period 2024-2034. The market will grow due to factors such as the growing demand for personalized medicine, the prevalence of chronic diseases on the rise, government and private funding, collaborations and partnerships, and advancements in genomic technologies.

A personalized medicine approach considers the differences in each patient's genetic makeup, lifestyle, and environment. Patients who are more likely to respond to a given medication can be identified using genomic biomarkers. This may result in more focused and efficient treatment plans. For instance, Illumina announced in February 2024 the release of the new NovaSeq X Plus sequencing technology, which provides better throughput and quicker run times for NGS applications in clinical and genomics research contexts.

By type, the predictive biomarkers segment accounted for the highest revenue-grossing segment in the global genomics biomarkers market in 2023 owing to the growing demand for personalized medicine and targeted therapies, which rely heavily on predictive biomarkers to tailor treatments to individual genetic profiles. For instance, in April 2024, Thermo Fisher Scientific purchased Ion Torrent, a supplier of semiconductor-based sequencing technology, increasing the range of NGS products they offer for the development and identification of biomarkers. Additionally, the prognostic biomarkers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on disease prognosis and patient outcomes, driving the demand for prognostic biomarkers for early prediction and management of diseases.

By disease indication, the oncology segment accounted for the highest revenue-grossing segment in the global genomics biomarkers market in 2023 owing to the growing prevalence of cancer and the need for precision medicine approaches, where genomics biomarkers play a crucial role in diagnosis, prognosis, and treatment selection. For instance, in March 2024, QIAGEN used its experience in sample preparation and biomarker analysis to work with a top pharmaceutical company to produce a companion diagnostic test for a new cancer treatment. Additionally, the neurological diseases segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing understanding of the genetic basis of neurological disorders and the development of targeted therapies, driving demand for genomics biomarkers for early detection and personalized treatment approaches.

By validation, the analytical validation segment accounted for the highest revenue-grossing segment in the global genomics biomarkers market in 2023 owing to the stringent regulatory requirements and the need for robust validation processes to ensure accuracy, reproducibility, and reliability of genomics biomarker tests, especially in clinical settings. For instance, F. Hoffmann-La Roche in December 2023 obtained FDA permission for a novel liquid biopsy test that makes use of technologies from their subsidiary Foundation Medicine to find genetic changes in cancer patients that can help with therapy selection. Additionally, the clinical validation segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of genomics biomarkers in clinical practice and the emphasis on validating their clinical utility for disease diagnosis, prognosis, and treatment selection.

By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global genomics biomarkers market in 2023 owing to the growing integration of genomics biomarkers into routine clinical practice and the increasing adoption of personalized medicine approaches in hospital settings. For instance, in January 2024, Agilent Technologies and a significant university partnered to create a new bioinformatics platform designed to analyze and interpret complicated genomic biomarker data. Additionally, the research laboratories segment is predicted to grow at the fastest CAGR during the forecast period owing to the expanding research activities in genomics, biomarker discovery, and drug development, driving demand for genomics biomarkers and related services in research laboratory settings.

North American region is anticipated to have the highest revenue share during the forecast period owing to the robust investment in genomics research, advanced healthcare infrastructure, and favorable regulatory environment, fostering widespread adoption of genomics biomarkers in North America. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness about personalized medicine, rising healthcare expenditure, and growing investments in genomics research and healthcare infrastructure in the Asia Pacific region. For instance, PerkinElmer introduced a new digital PCR platform in October 2023 that offers improved sensitivity and precision for identifying uncommon genomic biomarkers linked to a range of disorders.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Type, Disease Indication, Validation, and End-User
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement

Segmentation: Genomics Biomarkers Market Report 2023 - 2034

Genomics Biomarkers Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)

  • Predictive Biomarkers
  • Prognostic Biomarker

Genomics Biomarkers Market Analysis & Forecast by Disease Indication 2023 - 2034 (Revenue USD Bn)

  • Oncology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Renal Disorders
  • Others

Genomics Biomarkers Market Analysis & Forecast by Validation 2023 - 2034 (Revenue USD Bn)

  • Analytical Validation
  • Clinical Validation
  • Clinical Utility

Genomics Biomarkers Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

  • Diagnostic
  • Research Laboratories
  • Hospitals
  • Others

Genomics Biomarkers Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Genomics Biomarkers Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.1.1. Precision Medicine Advancements
5.1.2. Technological Advancements
5.1.3. Collaborative Research Initiatives
5.1.4. Growing Investment in Healthcare
5.2. Restraints Analysis
5.2.1. Regulatory Hurdles
5.2.2. Data Privacy Concerns
5.2.3. Limited Reimbursement Policies
5.3. Opportunities Analysis
5.3.1. Expansion in Emerging Markets
5.3.2. Integration with AI and Big Data Analytics
5.3.3. Adoption of Biomarker-Based Clinical Trials
5.4. Threats Analysis
5.4.1. Intellectual Property Issues
5.4.2. Data Security Risks
5.4.3. Reimbursement Challenges
5.5. Trend Analysis
5.5.1. Multi-Omics Approach
5.5.2. Microbiome Analysis
5.5.3. Growing adoption of pharmacogenomic testing
6. COVID-19 Impact Analysis
7. Genomics Biomarkers Market: Type Estimates & Trend Analysis
7.1. Type Segment Opportunity Analysis
7.2. Predictive Biomarkers
7.2.1. Predictive Biomarkers Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Prognostic Biomarker
7.3.1. Prognostic Biomarker Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Genomics Biomarkers Market: Disease Indication Estimates & Trend Analysis
8.1. Disease Indication Segment Opportunity Analysis
8.2. Oncology
8.2.1. Oncology Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Cardiovascular Diseases
8.3.1. Cardiovascular Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Neurological Diseases
8.4.1. Neurological Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Renal Disorders
8.5.1. Renal Disorders Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.6. Others
8.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Genomics Biomarkers Market: Validation Estimates & Trend Analysis
9.1. Validation Segment Opportunity Analysis
9.2. Analytical Validation
9.2.1. Analytical Validation Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Clinical Validation
9.3.1. Clinical Validation Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Clinical Utility
9.4.1. Clinical Utility Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Genomics Biomarkers Market: End-user Estimates & Trend Analysis
10.1. End-user Segment Opportunity Analysis
10.2. Diagnostic
10.2.1. Diagnostic Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Research Laboratories
10.3.1. Research Laboratories Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.4. Hospitals
10.4.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.5. Others
10.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Regional Market Analysis
11.1. Regional Market Opportunity Analysis
12. North America Genomics Biomarkers Market
12.1. North America Genomics Biomarkers Market
12.1.1. North America Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. North America Genomics Biomarkers Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. North America Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.1.4. North America Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
12.1.5. North America Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
12.1.6. North America Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. U.S. Global Genomics Biomarkers Market
12.2.1. U.S. Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. U.S. Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.2.3. U.S. Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
12.2.4. U.S. Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
12.2.5. U.S. Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. Canada Global Genomics Biomarkers Market
12.3.1. Canada Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. Canada Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.3.3. Canada Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
12.3.4. Canada Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
12.3.5. Canada Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Europe Global Genomics Biomarkers Market
13.1. Europe Global Genomics Biomarkers Market
13.1.1. Europe Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Europe Genomics Biomarkers Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Europe Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.1.4. Europe Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.1.5. Europe Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
13.1.6. Europe Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Germany Global Genomics Biomarkers Market
13.2.1. Germany Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Germany Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.2.3. Germany Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.2.4. Germany Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
13.2.5. Germany Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. UK Global Genomics Biomarkers Market
13.3.1. UK Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. UK Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.3.3. UK Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.3.4. UK Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
13.3.5. UK Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. France Global Genomics Biomarkers Market
13.4.1. France Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. France Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.4.3. France Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.4.4. France Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
13.4.5. France Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. Spain Global Genomics Biomarkers Market
13.5.1. Spain Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Spain Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.5.3. Spain Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.5.4. Spain Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
13.5.5. Spain Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Italy Global Genomics Biomarkers Market
13.6.1. Italy Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Italy Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.6.3. Italy Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.6.4. Italy Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
13.6.5. Italy Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Europe Global Genomics Biomarkers Market
13.7.1. Rest of Europe Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Europe Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Europe Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Europe Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
13.7.5. Rest of Europe Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Asia Pacific Global Genomics Biomarkers Market
14.1. Asia Pacific Global Genomics Biomarkers Market
14.1.1. Asia Pacific Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Asia Pacific Genomics Biomarkers Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Asia Pacific Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.1.4. Asia Pacific Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.1.5. Asia Pacific Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
14.1.6. Asia Pacific Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Japan Global Genomics Biomarkers Market
14.2.1. Japan Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Japan Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.2.3. Japan Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.2.4. Japan Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
14.2.5. Japan Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. China Global Genomics Biomarkers Market
14.3.1. China Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. China Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.3.3. China Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.3.4. China Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
14.3.5. China Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. India Global Genomics Biomarkers Market
14.4.1. India Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. India Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.4.3. India Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.4.4. India Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
14.4.5. India Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. South Korea Global Genomics Biomarkers Market
14.5.1. South Korea Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. South Korea Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.5.3. South Korea Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.5.4. South Korea Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
14.5.5. South Korea Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.6. Australia Global Genomics Biomarkers Market
14.6.1. Australia Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.6.2. Australia Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.6.3. Australia Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.6.4. Australia Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
14.6.5. Australia Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.7. Rest of Asia Pacific Global Genomics Biomarkers Market
14.7.1. Rest of Asia Pacific Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.7.2. Rest of Asia Pacific Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.7.3. Rest of Asia Pacific Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.7.4. Rest of Asia Pacific Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
14.7.5. Rest of Asia Pacific Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. Latin America Global Genomics Biomarkers Market
15.1. Latin America Global Genomics Biomarkers Market
15.1.1. Latin America Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. Latin America Genomics Biomarkers Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. Latin America Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.1.4. Latin America Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.1.5. Latin America Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
15.1.6. Latin America Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. Brazil Global Genomics Biomarkers Market
15.2.1. Brazil Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. Brazil Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.2.3. Brazil Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.2.4. Brazil Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
15.2.5. Brazil Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. Mexico Global Genomics Biomarkers Market
15.3.1. Mexico Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. Mexico Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.3.3. Mexico Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.3.4. Mexico Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
15.3.5. Mexico Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Argentina Global Genomics Biomarkers Market
15.4.1. Argentina Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Argentina Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.4.3. Argentina Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.4.4. Argentina Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
15.4.5. Argentina Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.5. Rest of Latin America Global Genomics Biomarkers Market
15.5.1. Rest of Latin America Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.5.2. Rest of Latin America Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.5.3. Rest of Latin America Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.5.4. Rest of Latin America Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
15.5.5. Rest of Latin America Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. MEA Global Genomics Biomarkers Market
16.1. MEA Global Genomics Biomarkers Market
16.1.1. MEA Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. MEA Genomics Biomarkers Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. MEA Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.1.4. MEA Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.1.5. MEA Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
16.1.6. MEA Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.2. GCC Global Genomics Biomarkers Market
16.2.1. GCC Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. GCC Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.2.3. GCC Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.2.4. GCC Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
16.2.5. GCC Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.3. South Africa Global Genomics Biomarkers Market
16.3.1. South Africa Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. South Africa Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.3.3. South Africa Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.3.4. South Africa Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
16.3.5. South Africa Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.4. Rest of MEA Global Genomics Biomarkers Market
16.4.1. Rest of MEA Genomics Biomarkers Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. Rest of MEA Genomics Biomarkers Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
16.4.3. Rest of MEA Genomics Biomarkers Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.4.4. Rest of MEA Genomics Biomarkers Market Size and Forecast, By Validation, 2023-2034 (Revenue USD Bn)
16.4.5. Rest of MEA Genomics Biomarkers Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17. Competitor Analysis
17.1. Company Market Share Analysis, 2023
17.2. Major Recent Developments
18. Company Profiles
18.1. Illumina, Inc.
18.2. Thermo Fisher Scientific, Inc.
18.3. QIAGEN N.V.
18.4. F. Hoffmann-La Roche Ltd.
18.5. Bio-Rad Laboratories, Inc.
18.6. Agilent Technologies, Inc.
18.7. PerkinElmer, Inc.
18.8. Pacific Biosciences of California, Inc.
18.9. Myriad Genetics, Inc.
18.10. Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation)
18.11. Foundation Medicine, Inc. (a subsidiary of Roche)
18.12. BGI Group
18.13. Eurofins Scientific
18.14. NanoString Technologies, Inc.
18.15. Guardant Health, Inc.
19. Conclusion20. Recommendations

Companies Mentioned

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Pacific Biosciences of California Inc.
  • Myriad Genetics Inc.
  • Genomic Health Inc. (a subsidiary of Exact Sciences Corporation)
  • Foundation Medicine Inc. (a subsidiary of Roche)
  • BGI Group
  • Eurofins Scientific
  • NanoString Technologies Inc.
  • Guardant Health Inc.

Table Information